Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ledwidge

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Biochimica Et Biophysica Acta|December 17, 2013
Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactionsShane O'Sullivan, Carlos Medina, Mark Ledwidge, et al.
International Journal of Cardiology|December 3, 2005
Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history studyJohn M Cahill, Enda Ryan, Bronagh Travers, et al.
European Journal of Heart Failure|March 1, 2008
Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failureMary Ryder, Niamh F Murphy, Dermot McCaffrey, et al.
Diabetes Research and Clinical Practice|December 31, 2017
Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and managementNadezhda Glezeva, Master Chisale, Kenneth McDonald, et al.
International Journal of Cardiology|October 15, 2008
Quality of life predicts outcome in a heart failure disease management programChristina O'Loughlin, Niamh F Murphy, Carmel Conlon, et al.
Tropical Medicine & International Health : TM & IH|January 20, 2015
Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnosticsNadezhda Glezeva, Joe Gallagher, Mark Ledwidge, et al.
Research in Social & Administrative Pharmacy : RSAP|February 14, 2025
Advanced pharmacy service provision in community pharmacy across the United Kingdom and Ireland: A Scoping reviewMuireann Counihan, Isabella Stein, Cecilia Flynn, et al.
JACC. Basic to Translational Science|July 5, 2021
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart FailureValentina Cannone, Mark Ledwidge, Chris Watson, et al.
Journal of Cardiac Failure|December 3, 2014
Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesisNadezhda Glezeva, Victor Voon, Chris Watson, et al.
Journal of Cardiovascular Translational Research|April 30, 2013
Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptideNadezhda Glezeva, Patrick Collier, Victor Voon, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Biochimica Et Biophysica Acta|December 17, 2013
Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactionsShane O'Sullivan, Carlos Medina, Mark Ledwidge, et al.
International Journal of Cardiology|December 3, 2005
Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history studyJohn M Cahill, Enda Ryan, Bronagh Travers, et al.
European Journal of Heart Failure|March 1, 2008
Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failureMary Ryder, Niamh F Murphy, Dermot McCaffrey, et al.
Diabetes Research and Clinical Practice|December 31, 2017
Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and managementNadezhda Glezeva, Master Chisale, Kenneth McDonald, et al.
International Journal of Cardiology|October 15, 2008
Quality of life predicts outcome in a heart failure disease management programChristina O'Loughlin, Niamh F Murphy, Carmel Conlon, et al.
Tropical Medicine & International Health : TM & IH|January 20, 2015
Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnosticsNadezhda Glezeva, Joe Gallagher, Mark Ledwidge, et al.
Research in Social & Administrative Pharmacy : RSAP|February 14, 2025
Advanced pharmacy service provision in community pharmacy across the United Kingdom and Ireland: A Scoping reviewMuireann Counihan, Isabella Stein, Cecilia Flynn, et al.
JACC. Basic to Translational Science|July 5, 2021
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart FailureValentina Cannone, Mark Ledwidge, Chris Watson, et al.
Journal of Cardiac Failure|December 3, 2014
Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesisNadezhda Glezeva, Victor Voon, Chris Watson, et al.
Journal of Cardiovascular Translational Research|April 30, 2013
Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptideNadezhda Glezeva, Patrick Collier, Victor Voon, et al.
Pageof 11